Yüklüyor......
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...
Kaydedildi:
| Yayımlandı: | Breast Cancer (Auckl) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Libertas Academica
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214808/ https://ncbi.nlm.nih.gov/pubmed/28096680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S12443 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|